GITNUX MARKETDATA REPORT 2024

The Most Surprising Cell Therapy Industry Statistics in 2024

Statistic 1

"The oncology application segment held the largest share of over 52% in the cell therapy market in 2020."

Sources Icon

Statistic 2

"The mesenchymal stem cell (MSC) segment is predicted to witness the fastest growth, at a CAGR of 14.2% from 2020 to 2027."

Sources Icon

Statistic 3

"The cost of manufacturing cell therapies can range from $20,000 to $500,000 per patient."

Sources Icon

Statistic 4

"Cell therapies for neurological disorders represent about 25% of the total market."

Sources Icon

Statistic 5

"The autoimmune disease segment is anticipated to witness significant growth, with a CAGR of 11.0% from 2020 to 2027."

Sources Icon

Statistic 6

"In 2020, the market for autologous cell therapy (cells derived from the patient’s own body) was valued at $3.2 billion."

Sources Icon

Statistic 7

"More than 1,000 companies globally are involved in different stages of cell therapy development and commercialization."

Sources Icon

Statistic 8

"China is rapidly emerging as a significant player in the cell therapy market, with over 200 active cell therapy companies."

Sources Icon

Statistic 9

"The cardiovascular category within the cell therapy market is projected to grow at a CAGR of 11.8% from 2020 to 2027."

Sources Icon

Statistic 10

"Out of all cell therapies, CAR-T cell therapies are expected to dominate the market due to their success in treating lymphomas."

Sources Icon

Statistic 11

"The adoption of GMP (Good Manufacturing Practices) for cell therapy manufacturing has increased by more than 50% over the past five years."

Sources Icon

Statistic 12

"The global cell therapy market is expected to reach $8.83 billion by 2025."

Sources Icon

Statistic 13

"By 2027, it is estimated that over 500 cell-based clinical trials will be underway globally."

Sources Icon

Statistic 14

"The rise in partnerships and collaborations in the cell therapy industry increased by 30% from 2019 to 2021."

Sources Icon

Statistic 15

"Asia-Pacific is expected to witness the highest growth, with a CAGR of 10.1% during the forecast period (2020-2025)."

Sources Icon

Statistic 16

"Nearly 80% of cell therapy clinical trials are conducted in academic and hospital settings rather than commercial labs."

Sources Icon

Statistic 17

"Roughly 60% of cell therapies are still in preclinical trial phases."

Sources Icon

Statistic 18

"North America holds the largest share in the cell therapy market, accounting for over 43% of the global market."

Sources Icon

Statistic 19

"The cell therapy regulatory framework in the United States and the European Union is becoming increasingly harmonized."

Sources Icon

Statistic 20

"The cell therapy market faced a temporary dip in growth due to the COVID-19 pandemic but is expected to recover strongly post-2021."

Sources Icon

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!